Business Context and Reporting Period
Ryan Specialty Holdings, Inc. filed this Form 8-K under Item 8.01 on May 22, 2023, with the report signed on May 24, 2023. The filing concerns a secondary offering of the company’s Class A common stock by selling shareholders.
Transaction and Key Financial Information
- Selling shareholders agreed to sell 9,000,000 Class A common shares to Barclays Capital Inc. at $43.45 per share.
- The aggregate offering value was approximately $391.1 million before underwriting discounts, commissions, and other expenses.
- Ryan Specialty will not receive any proceeds from the sale.
- The shares were registered under the company’s automatic shelf registration statement on Form S-3ASR, filed May 22, 2023.
- Delivery against payment was expected on May 25, 2023.
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance metrics.
Material Changes Versus Prior Period
The filing does not report a change in operating results or financial condition versus a prior comparable period. The primary disclosed event is the planned secondary sale of shares by existing shareholders, which does not provide capital to the company.
Outlook, Risks, Contingencies, and Unusual Items
- The underwriting agreement contains customary representations, warranties, covenants, closing conditions, and indemnification obligations, including obligations relating to Securities Act liabilities.
- The transaction remained subject to customary closing conditions at the filing date.
- The filing states that the agreement’s representations and warranties were made for the parties’ contractual purposes, as of specified dates, and may be subject to negotiated limitations.
- No management guidance, business outlook, operating risks, contingencies, or unusual accounting items are provided.
Investor Verification Items
- Verify completion and settlement of the offering on or about May 25, 2023.
- Review the underwriting agreement filed as Exhibit 1.1 for transaction terms, indemnification provisions, and closing conditions.
- Confirm the final number of shares sold and the identity and ownership interests of the selling shareholders.
- Review the company’s subsequent filings for any effect on share ownership, public float, or market price.
- Review Exhibit 99.1 for the disclosed estimated expenses of issuance and distribution.